459 related articles for article (PubMed ID: 9009935)
1. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.
Minto CF; Schnider TW; Egan TD; Youngs E; Lemmens HJ; Gambus PL; Billard V; Hoke JF; Moore KH; Hermann DJ; Muir KT; Mandema JW; Shafer SL
Anesthesiology; 1997 Jan; 86(1):10-23. PubMed ID: 9009935
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery.
Drover DR; Lemmens HJ
Anesthesiology; 1998 Oct; 89(4):869-77. PubMed ID: 9778004
[TBL] [Abstract][Full Text] [Related]
3. An Allometric Model of Remifentanil Pharmacokinetics and Pharmacodynamics.
Eleveld DJ; Proost JH; Vereecke H; Absalom AR; Olofsen E; Vuyk J; Struys MMRF
Anesthesiology; 2017 Jun; 126(6):1005-1018. PubMed ID: 28509794
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application.
Minto CF; Schnider TW; Shafer SL
Anesthesiology; 1997 Jan; 86(1):24-33. PubMed ID: 9009936
[TBL] [Abstract][Full Text] [Related]
5. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers.
Egan TD; Minto CF; Hermann DJ; Barr J; Muir KT; Shafer SL
Anesthesiology; 1996 Apr; 84(4):821-33. PubMed ID: 8638836
[TBL] [Abstract][Full Text] [Related]
6. Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I-III patients.
Bienert A; Wiczling P; Zaba C; Zaba Z; Wolc A; Marciniak R; Grześkowiak E; Kusza K
Arzneimittelforschung; 2011; 61(10):545-52. PubMed ID: 22164962
[TBL] [Abstract][Full Text] [Related]
7. Measured context-sensitive half-times of remifentanil and alfentanil.
Kapila A; Glass PS; Jacobs JR; Muir KT; Hermann DJ; Shiraishi M; Howell S; Smith RL
Anesthesiology; 1995 Nov; 83(5):968-75. PubMed ID: 7486182
[TBL] [Abstract][Full Text] [Related]
8. A review of the pharmacokinetics and pharmacodynamics of remifentanil.
Glass PSA; Gan TJ; Howell S
Anesth Analg; 1999 Oct; 89(4 Suppl):7. PubMed ID: 10511072
[No Abstract] [Full Text] [Related]
9. Population pharmacokinetics study of remifentanil in Chinese adult patients determined by an LC-MS/MS method.
Zhang C; Zhang L; Zhang X; Yang L; Zhai S; Duan L
Int J Clin Pharmacol Ther; 2008 Sep; 46(9):477-88. PubMed ID: 18793578
[TBL] [Abstract][Full Text] [Related]
10. Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal.
Egan TD
Clin Pharmacokinet; 1995 Aug; 29(2):80-94. PubMed ID: 7586903
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and electroencephalogram response of remifentanil alone and in combination with esmolol in the rat.
Haidar SH; Moreton JE; Liang Z; Hoke JF; Muir KT; Eddington ND
Pharm Res; 1997 Dec; 14(12):1817-23. PubMed ID: 9453074
[TBL] [Abstract][Full Text] [Related]
12. The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model.
Cox EH; Langemeijer MW; Gubbens-Stibbe JM; Muir KT; Danhof M
Anesthesiology; 1999 Feb; 90(2):535-44. PubMed ID: 9952162
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers.
Egan TD; Lemmens HJ; Fiset P; Hermann DJ; Muir KT; Stanski DR; Shafer SL
Anesthesiology; 1993 Nov; 79(5):881-92. PubMed ID: 7902032
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacodynamics and pharmacokinetics of remifentanil: overview and comparison with other opioids].
Kato M; Satoh D; Okada Y; Sugiyama K; Toda N; Kurosawa S
Masui; 2007 Nov; 56(11):1281-6. PubMed ID: 18027596
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery.
Westmoreland CL; Hoke JF; Sebel PS; Hug CC; Muir KT
Anesthesiology; 1993 Nov; 79(5):893-903. PubMed ID: 7902033
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures.
Ross AK; Davis PJ; Dear Gd GL; Ginsberg B; McGowan FX; Stiller RD; Henson LG; Huffman C; Muir KT
Anesth Analg; 2001 Dec; 93(6):1393-401, table of contents. PubMed ID: 11726413
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease.
Dershwitz M; Hoke JF; Rosow CE; Michałowski P; Connors PM; Muir KT; Dienstag JL
Anesthesiology; 1996 Apr; 84(4):812-20. PubMed ID: 8638835
[TBL] [Abstract][Full Text] [Related]
18. [Characterization of dose profile of remifentanil with computer simulation: comparative study with fentanyl and alfentanyl].
Gambús PL; Schnider TW; Minto CF
Rev Esp Anestesiol Reanim; 1998 Oct; 45(8):317-25. PubMed ID: 9847642
[TBL] [Abstract][Full Text] [Related]
19. Influence of hemorrhagic shock on remifentanil: a pharmacokinetic and pharmacodynamic analysis.
Johnson KB; Kern SE; Hamber EA; McJames SW; Kohnstamm KM; Egan TD
Anesthesiology; 2001 Feb; 94(2):322-32. PubMed ID: 11176098
[TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetic Modeling of Remifentanil in Infants with Unrepaired Tetralogy of Fallot.
Chang J; Shen Y; Huang Y; Sun Y; Cai MH; Niu J; Zhang LM; Zheng JJ; Zhang MZ
Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):53-62. PubMed ID: 29915955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
